| Chugai Pharmaceutical (CHGCY) |
Japan |
$89.845B |
31.38 |
| Takeda Pharmaceutical (TAK) |
Japan |
$56.639B |
11.12 |
| Zoetis (ZTS) |
United States |
$55.849B |
19.99 |
| BeOne Medicines - (ONC) |
Switzerland |
$38.053B |
201.74 |
| Sandoz Group AG (SDZNY) |
Switzerland |
$34.527B |
0.00 |
| Daiichi Sankyo, - (DSNKY) |
Japan |
$34.382B |
17.12 |
| United Therapeutics (UTHR) |
United States |
$20.621B |
18.15 |
| Merck (MKKGY) |
Germany |
$18.598B |
11.47 |
| Shionogi (SGIOY) |
Japan |
$18.477B |
14.29 |
| Neurocrine Biosciences (NBIX) |
United States |
$13.752B |
33.00 |
| Ionis Pharmaceuticals (IONS) |
United States |
$13.522B |
0.00 |
| IPSEN (IPSEY) |
France |
$13.306B |
0.00 |
| Orion OYJ (ORINY) |
Finland |
$11.502B |
32.86 |
| Summit Therapeutics (SMMT) |
United States |
$10.680B |
0.00 |
| Madrigal Pharmaceuticals (MDGL) |
United States |
$10.525B |
0.00 |
| Eisai (ESAIY) |
|
$8.400B |
0.00 |
| Ono Pharmaceutical (OPHLF) |
Japan |
$7.149B |
17.10 |
| Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$4.947B |
0.00 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$4.643B |
22.05 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$4.576B |
0.00 |
| Indivior Pharmaceuticals (INDV) |
United States |
$4.307B |
17.58 |
| Stevanato Group S.p.A (STVN) |
Italy |
$4.285B |
23.98 |
| Corcept Therapeutics (CORT) |
United States |
$4.035B |
43.59 |
| NewAmsterdam Pharma (NAMS) |
Netherlands |
$3.635B |
0.00 |
| Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$3.164B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$2.939B |
9.38 |
| Hypermarcas (HYPMY) |
Brazil |
$2.793B |
19.17 |
| Dyne Therapeutics (DYN) |
United States |
$2.364B |
0.00 |
| Soleno Therapeutics (SLNO) |
United States |
$2.126B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$2.109B |
0.00 |
| Ocular Therapeutix (OCUL) |
United States |
$1.898B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.880B |
22.28 |
| Harrow (HROW) |
United States |
$1.706B |
104.68 |
| Ardelyx (ARDX) |
United States |
$1.701B |
0.00 |
| Enliven Therapeutics (ELVN) |
United States |
$1.602B |
0.00 |
| Definium Therapeutics (DFTX) |
United States |
$1.601B |
0.00 |
| Oruka Therapeutics (ORKA) |
United States |
$1.521B |
0.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$1.483B |
7.34 |
| Amylyx Pharmaceuticals (AMLX) |
United States |
$1.427B |
0.00 |
| Relay Therapeutics (RLAY) |
United States |
$1.413B |
0.00 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$1.315B |
78.00 |
| Evotec AG (EVO) |
Germany |
$1.251B |
0.00 |
| Xeris Biopharma Holdings (XERS) |
United States |
$1.147B |
0.00 |
| Savara (SVRA) |
United States |
$1.050B |
0.00 |
| Theravance Biopharma (TBPH) |
United States |
$0.992B |
41.66 |
| Aktis Oncology (AKTS) |
United States |
$0.991B |
0.00 |
| Cronos Group (CRON) |
Canada |
$0.977B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
United States |
$0.956B |
0.00 |
| Xencor (XNCR) |
United States |
$0.773B |
0.00 |
| Esperion Therapeutics (ESPR) |
United States |
$0.760B |
0.00 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.728B |
0.00 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$0.724B |
17.11 |
| Nektar Therapeutics (NKTR) |
United States |
$0.714B |
0.00 |
| Bioventus (BVS) |
United States |
$0.679B |
13.91 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.603B |
5.38 |
| Altimmune (ALT) |
United States |
$0.555B |
0.00 |
| ProKidney (PROK) |
United States |
$0.520B |
0.00 |
| Lexeo Therapeutics (LXEO) |
United States |
$0.503B |
0.00 |
| Lyell Immunopharma (LYEL) |
United States |
$0.481B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
United States |
$0.479B |
0.00 |
| Organogenesis (ORGO) |
United States |
$0.471B |
0.00 |
| Zevra Therapeutics (ZVRA) |
United States |
$0.471B |
0.00 |
| Aquestive Therapeutics (AQST) |
United States |
$0.468B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.466B |
6.38 |
| Nature's Sunshine Products (NATR) |
United States |
$0.459B |
27.33 |
| Elite Pharmaceuticals (ELTP) |
United States |
$0.405B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$0.380B |
10.62 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.367B |
0.00 |
| Akebia Therapeutics (AKBA) |
United States |
$0.366B |
0.00 |
| Protara Therapeutics (TARA) |
United States |
$0.336B |
0.00 |
| Aldeyra Therapeutics (ALDX) |
United States |
$0.306B |
0.00 |
| Cybin (HELP) |
Canada |
$0.292B |
0.00 |
| Journey Medical (DERM) |
United States |
$0.278B |
0.00 |
| Enlivex Therapeutics (ENLV) |
Israel |
$0.275B |
0.00 |
| Relmada Therapeutics (RLMD) |
United States |
$0.264B |
0.00 |
| Larimar Therapeutics (LRMR) |
United States |
$0.254B |
0.00 |
| Avalo Therapeutics (AVTX) |
United States |
$0.243B |
0.00 |
| OmniAb (OABI) |
United States |
$0.238B |
0.00 |
| Profound Medical (PROF) |
Canada |
$0.229B |
0.00 |
| Heron Therapeutics (HRTX) |
United States |
$0.222B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.221B |
0.00 |
| Silence Therapeutics (SLN) |
United Kingdom |
$0.214B |
0.00 |
| Achieve Life Sciences (ACHV) |
Canada |
$0.210B |
0.00 |
| Context Therapeutics (CNTX) |
United States |
$0.208B |
0.00 |
| Minerva Neurosciences (NERV) |
United States |
$0.183B |
0.00 |
| Galectin Therapeutics (GALT) |
United States |
$0.182B |
0.00 |
| Surrozen (SRZN) |
United States |
$0.182B |
0.00 |
| Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.182B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.181B |
0.00 |
| AleAnna (ANNA) |
United States |
$0.173B |
0.00 |
| VAXART, INC (VXRT) |
United States |
$0.150B |
0.00 |
| Century Therapeutics (IPSC) |
United States |
$0.146B |
0.00 |
| Unicycive Therapeutics (UNCY) |
United States |
$0.133B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.130B |
0.00 |
| Prelude Therapeutics (PRLD) |
United States |
$0.127B |
0.00 |
| Avita Medical (RCEL) |
United States |
$0.120B |
0.00 |
| Inhibikase Therapeutics (IKT) |
United States |
$0.119B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
United States |
$0.112B |
0.00 |
| Korro Bio (KRRO) |
United States |
$0.109B |
0.00 |
| Cardiol Therapeutics (CRDL) |
Canada |
$0.107B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
United States |
$0.106B |
0.00 |
| Vivani Medical (VANI) |
United States |
$0.096B |
0.00 |
| Pyxis Oncology (PYXS) |
United States |
$0.096B |
0.00 |
| Cassava Sciences (SAVA) |
United States |
$0.091B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.091B |
38.41 |
| Incannex Healthcare (IXHL) |
Australia |
$0.087B |
0.00 |
| Assertio Holdings (ASRT) |
United States |
$0.075B |
0.00 |
| PolyPid (PYPD) |
Israel |
$0.069B |
0.00 |
| Gain Therapeutics (GANX) |
United States |
$0.062B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.061B |
0.00 |
| Procaps Group, S.A (PROCF) |
Luxembourg |
$0.058B |
0.00 |
| Liminatus Pharma (LIMN) |
United States |
$0.055B |
0.00 |
| Dominari Holdings (DOMH) |
United States |
$0.055B |
0.00 |
| Fractyl Health (GUTS) |
United States |
$0.055B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
United States |
$0.054B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.054B |
44.88 |
| Nutriband (NTRB) |
United States |
$0.053B |
0.00 |
| BioNxt Solutions (BNXTF) |
Canada |
$0.052B |
0.00 |
| Acrivon Therapeutics (ACRV) |
United States |
$0.050B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
United States |
$0.050B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.043B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.041B |
0.00 |
| FibroGen (FGEN) |
United States |
$0.039B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
United States |
$0.039B |
0.00 |
| Talphera (TLPH) |
United States |
$0.037B |
0.00 |
| Mural Oncology (MURA) |
Ireland |
$0.035B |
0.00 |
| Lite Strategy (LITS) |
United States |
$0.035B |
0.00 |
| Plus Therapeutics (PSTV) |
United States |
$0.032B |
0.00 |
| Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.029B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.029B |
0.00 |
| Wellgistics Health (WGRX) |
United States |
$0.029B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.028B |
0.00 |
| TherapeuticsMD (TXMD) |
United States |
$0.025B |
0.00 |
| Jupiter Neurosciences (JUNS) |
United States |
$0.021B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.019B |
0.00 |
| VYNE Therapeutics (VYNE) |
United States |
$0.019B |
0.00 |
| Scienture Holdings (SCNX) |
United States |
$0.017B |
0.00 |
| Cosmos Health (COSM) |
United States |
$0.016B |
0.00 |
| Klotho Neurosciences (KLTO) |
United States |
$0.016B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.015B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
United States |
$0.015B |
0.00 |
| Vivos Therapeutics (VVOS) |
United States |
$0.014B |
0.00 |
| Mannatech (MTEX) |
United States |
$0.014B |
0.00 |
| Traws Pharma (TRAW) |
United States |
$0.014B |
0.02 |
| Inotiv (NOTV) |
United States |
$0.013B |
0.00 |
| Vyome Holdings (HIND) |
United States |
$0.013B |
0.00 |
| BioLineRx (BLRX) |
Israel |
$0.013B |
0.00 |
| CASI Pharmaceuticals (CASI) |
China |
$0.012B |
0.00 |
| Tempest Therapeutics (TPST) |
United States |
$0.011B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.009B |
0.00 |
| Ainos (AIMD) |
United States |
$0.009B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
Israel |
$0.009B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
United States |
$0.009B |
0.00 |
| TransCode Therapeutics (RNAZ) |
United States |
$0.009B |
0.00 |
| BioVie (BIVI) |
United States |
$0.008B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
United States |
$0.008B |
0.00 |
| Curanex Pharmaceuticals Inc (CURX) |
United States |
$0.008B |
0.00 |
| Nuvilex (PMCB) |
United States |
$0.007B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.007B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
United States |
$0.007B |
0.00 |
| Mangoceuticals (MGRX) |
United States |
$0.006B |
0.00 |
| Alaunos Therapeutics (TCRT) |
United States |
$0.005B |
0.00 |
| Ernexa Therapeutics (ERNA) |
United States |
$0.005B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.005B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.005B |
0.00 |
| Heatwurx (PCSA) |
United States |
$0.005B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
United States |
$0.005B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.005B |
0.00 |
| Aptorum Group (APM) |
United Kingdom |
$0.005B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.004B |
0.00 |
| Indaptus Therapeutics (INDP) |
United States |
$0.003B |
0.00 |
| Lyra Therapeutics (LYRA) |
United States |
$0.003B |
0.00 |
| XORTX Therapeutics (XRTX) |
Canada |
$0.003B |
0.00 |
| InMed Pharmaceuticals (INM) |
Canada |
$0.003B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
China |
$0.003B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.003B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
China |
$0.002B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.002B |
0.00 |
| SciSparc (SPRC) |
Israel |
$0.002B |
0.00 |
| Clearmind Medicine (CMND) |
Canada |
$0.002B |
0.00 |
| CDT Equity (CDT) |
United States |
$0.002B |
0.00 |
| PainReform (PRFX) |
Israel |
$0.001B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.001B |
0.00 |
| Aditxt (ADTX) |
United States |
$0.000B |
0.00 |
| Emisphere Technologies (EMIS) |
United States |
$0.000B |
0.00 |
| Grifols, S.A (GRFS) |
Spain |
$0.000B |
0.00 |
| 4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
| Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
